» » Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications : Proceedings of the Symposium on Novel Perspectives in Prostacy (International Congress Series)
Download Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications : Proceedings of the Symposium on Novel Perspectives in Prostacy (International Congress Series) djvu

Download Prostacyclin: New Perspectives for Basic Research and Novel Therapeutic Indications : Proceedings of the Symposium on Novel Perspectives in Prostacy (International Congress Series) djvu

by Gabor M. Rubanyi,John R. Vane

Author: Gabor M. Rubanyi,John R. Vane
Subcategory: Medicine & Health Sciences
Language: English
Publisher: Excerpta Medica (November 1, 1992)
Pages: 284 pages
Category: Other
Rating: 4.7
Other formats: rtf docx mobi mbr

1 2 3 4 5. Want to Read.

Presented at the symposium "New Approaches in the Therapy of Breast Cancer", Georgetown . Schirner M, Schneider MR: Antimetastatic potential of the stable prostacyclin analogue cicaprost.

Presented at the symposium "New Approaches in the Therapy of Breast Cancer", Georgetown University Medical Center, Washington DC, October 1994, generously supported by an education grant from Bristol-Myers Squibb. Excerpta Medica, Amsterdam, 1992, pp 247–275Google Scholar.

by Gabor M. Rubanyi, Victor J. Dzau, John P. Cooke. ISBN 9781420024616 (978-1-4200-2461-6) CRC, 2002.

For this requirement, the model, by definition, does not need to be a perfect replication of the clinical condition, but it is important that the validation provided for a given model is fit for purpose.

Perspectives on Science was established in 1993 and is published online and in hard copy by the MIT Press.

Nova publishes a wide array of books and journals from authors around the globe, focusing on Medicine and Health, Science and Technology and the Social Sciences and Humanities.

The first part of this proceedings volume deals with the three most relevant new areas of prostacyclin research: analysis of novel mechanisms of action in "traditional" target cells (vascular smooth muscle and platelets); study of the effect of prostacyclin on novel targets (e.g. endothelium); and examination and potential therapeutic use of the unique cytoprotective and antiatherosclerotic properties of prostacyclin. Based on the progress made in these basic research areas, the second part of the volume evaluates the potential new therapeutic applications of stable prostacyclin analogues in atherosclerosis, congestive heart failure, ischemic heart disease, diabetes, pregnancy, and tumor metastasis. No index. Annotation copyright Book News, Inc. Portland, Or.